Diagnostic Reagents for Infectious Diseases Market, By Product Type (Molecular Diagnostic Reagents, Immunoassay Reagents, Clinical Chemistry Reagents, and Hematology Reagents), By Technology, By Disease Type, By Application, By End-User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4699
|
Published Date
February 2026
|
Pages
356
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The Diagnostic Reagents for Infectious Diseases Market size was valued at US$ 3,315.31 Million in 2024, expanding at a CAGR of 9.23% from 2025 to 2032.
Diagnostic reagents for infectious diseases are critical biochemical substances used to accurately detect and identify bacteria, viruses, fungi, and parasites. The rising prevalence of infectious diseases, coupled with increasing demand for early and precise diagnosis across hospitals, laboratories, and point-of-care settings, is driving market growth. Significant opportunities exist in the development of high-sensitivity reagents compatible with rapid, automated, and decentralized diagnostic platforms, which are essential for outbreak management and timely clinical decision-making. A key trend is the advancement of molecular and immunoassay-based reagents that deliver faster turnaround times, enhanced specificity, and improved overall accuracy. However, challenges such as limited reagent stability, dependence on cold-chain storage, and variability in performance across different pathogens continue to constrain adoption, particularly in resource-limited environments and for long-term stockpiling in emergency preparedness initiatives. For instance, in 2024, the U.S. government allocated over $1.2 billion through the Biomedical Advanced Research and Development Authority (BARDA) to support the development and stockpiling of diagnostic reagents for infectious diseases, underscoring the critical role of public funding in bolstering global diagnostic preparedness.
Diagnostic Reagents for Infectious Diseases Market- Market Dynamics
Rising Prevalence of Infectious Diseases and Growing Demand for Diagnostic Testing
The increasing prevalence of infectious diseases, including respiratory infections, tuberculosis, HIV, and emerging viral outbreaks, is driving strong demand for diagnostic reagents, which are essential for accurate and timely disease detection. As healthcare systems prioritize early diagnosis and effective disease management, hospitals and laboratories require high-quality reagents that deliver sensitivity, specificity, and reproducibility across molecular, immunoassay, and rapid diagnostic platforms. The rising adoption of rapid and point-of-care testing further fuels demand for reagents that maintain consistent performance in compact, automated, and decentralized diagnostic systems. Additionally, expanding disease surveillance programs, routine screening initiatives, and national public health campaigns have significantly increased testing volumes in recent years. The growing emphasis on preventive healthcare, hospital infection control, and outbreak preparedness continues to reinforce the need for reliable, high-performance diagnostic reagents across diverse healthcare settings worldwide. For example, according to the World Health Organization (WHO), in 2024, over 5 billion diagnostic tests for infectious diseases were conducted globally, reflecting the scale of government-led and public health-driven testing initiatives.
Diagnostic Reagents for Infectious Diseases Market- Segmentation Analysis:
The Global Diagnostic Reagents for Infectious Diseases Market is segmented on the basis of Product Type, Technology, Disease Type, Application, End-User, and Region.
The diagnostic reagents for infectious diseases market is segmented into four primary product types: molecular diagnostic reagents, immunoassay reagents, clinical chemistry reagents, and hematology reagents. Molecular diagnostic reagents command the highest priority due to their exceptional sensitivity and specificity in detecting pathogen DNA or RNA, making them indispensable for the rapid and accurate diagnosis of viral and bacterial infections. This focus aligns with global public health strategies, as governments worldwide have significantly scaled up molecular testing capacity in response to pandemics and endemic infectious diseases: recent health reports indicate that more than 80% of national laboratory networks now integrate molecular diagnostics as a core component of infectious disease surveillance and response systems, reflecting sustained policy support and funding. Immunoassay reagents rank second in market importance, widely used in antigen–antibodybased testing owing to their reliability, scalability, and broad applicability across both pointofcare and centralized laboratory settings. Clinical chemistry reagents follow, playing a supportive role in monitoring biomarkers and disease progression — critical for comprehensive patient management during infection. Hematology reagents hold a smaller yet significant share, particularly in hospital laboratories, where they are essential for blood cell analysis and immune response monitoring. Overall, market prioritization is shaped by clinical utility, technological sophistication, and the growing global demand for rapid, highperformance diagnostic solutions that support public health objectives.
When categorized by technology type, the market comprises PCR & RTPCR, ELISA, immunofluorescence, and nextgeneration sequencing (NGS) platforms. PCR and RTPCR technologies hold the highest priority due to their widespread adoption, high analytical sensitivity, and rapid nucleic acidbased detection capabilities, establishing them as the gold standard in molecular diagnostics for infectious disease agents. This leadership is reinforced by national health policies that have funded expanded PCR infrastructure; for example, multiple countries report that over 70% of routine pathogen testing in public health laboratories is now conducted using PCRbased methods, reflecting governmental emphasis on accurate and early diagnosis. ELISA (enzymelinked immunosorbent assay) technologies rank second, valued for their robustness, ease of use, and suitability for detecting antigens and antibodies across a broad spectrum of infectious diseases in both clinical and decentralized testing environments. Immunofluorescence methods follow, offering highprecision visualization and detection of pathogens, especially in specialized laboratory applications, although their requirement for technical expertise moderates adoption compared with higherthroughput assays. Nextgeneration sequencing (NGS) is positioned as a promising technology for comprehensive pathogen profiling and outbreak tracking, increasingly featured in national genomic surveillance programs; however, its broader clinical implementation is currently constrained by higher costs and infrastructure demands. Overall, technological prioritization in the market reflects a balance between diagnostic sensitivity, operational usability, and scalability — priorities that are mirrored in global health system investments and policy frameworks aimed at strengthening infectious disease diagnostics.
Diagnostic Reagents for Infectious Diseases Market- Geographical Insights
North America leads the global market for diagnostic reagents for infectious diseases, accounting for the largest revenue share, driven by a robust healthcare infrastructure, substantial R&D investment, and widespread adoption of advanced molecular and immunoassay reagents across clinical and laboratory settings. The United States, in particular, dominates regional growth, supported by government-led screening initiatives and active participation from private diagnostic providers. Europe ranks second, with countries such as Germany, France, and the UK emphasizing early disease detection and high-quality reagent utilization, further strengthened by public-private partnerships that enhance testing capacity. The Asia-Pacific region is the fastest-growing market, propelled by increasing healthcare expenditure, expanding laboratory infrastructure, and a rising burden of infectious diseases in China, India, and Japan, which is driving local reagent production and adoption. Key strategic developments include bioMérieux’s acquisition of Day Zero Diagnostics in June 2025 to broaden its reagent portfolio and the October 2025 partnership between Sysmex and QIAGEN to enhance reagent supply and distribution in Japan.
Diagnostic Reagents for Infectious Diseases Market- Country Insights
At the country level, the United States holds a leading position in the diagnostic reagents for infectious diseases market, driven by advanced healthcare infrastructure, widespread adoption of molecular testing, and significant public and private investment in early disease detection. Western European nations, including Germany, the United Kingdom, and France, follow closely, supported by expanding laboratory networks and strong utilization of reagents in both clinical diagnostics and public health screening programs. In the Asia-Pacific region, China and India are experiencing rapid market expansion due to increased healthcare spending, rising infectious disease prevalence, and government initiatives aimed at localizing reagent supply chains, which reduce reliance on imports, improve accessibility, and lower costs. Key strategic developments include bioMérieux’s acquisition of Day Zero Diagnostics in June 2025 to expand its infectious disease reagent portfolio and next-generation sequencing (NGS) capabilities, and Sysmex’s October 2025 collaboration with QIAGEN to distribute infectious disease reagents and diagnostic products across Japan.
Diagnostic Reagents for Infectious Diseases Market- Competitive Landscape:
The diagnostic reagents for infectious diseases market is moderately consolidated, led by established players such as bioMérieux SA, QIAGEN, F. HoffmannLa Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation, and Sysmex Corporation. These companies maintain leadership through extensive reagent portfolios, global distribution networks, and continuous innovation in molecular and immunoassay technologies. Ongoing investments in R&D, reagent sensitivity, automation, and workflow integration differentiate market leaders while fostering healthy competition. Mergers and acquisitions are actively shaping market dynamics; for example, bioMérieux’s acquisition of Day Zero Diagnostics in June 2025 expanded its infectious disease reagent offerings and next-generation sequencing workflows. Strategic collaborations further strengthen competitive positioning, such as Sysmex’s partnership with QIAGEN in October 2025 for exclusive distribution of infectious disease reagents and diagnostic products in Japan. Smaller firms target niche reagent segments, developing specialized solutions that complement the broader innovation ecosystem.
Recent Developments:
- In January 2024, QIAGEN launched two new QIAstatDx syndromic test panels in India—the Gastrointestinal Panel 2 and the Meningitis/Encephalitis Panel—alongside the existing Respiratory SARSCoV2 Panel, enabling rapid, accurate, multiplex infectious disease diagnosis through realtime PCR and singleuse cartridges.
- In July 2025, Microbix Biosystems introduced its QUANTDx™ characterized reference materials, a product line offering accurately quantified and fully traceable reference materials across more than 80 panels for infectious disease assay development and validation, aimed at improving assay performance and supporting regulatory compliance.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Agilent Technologies
- Beckman Coulter
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Danaher Corporation
- DiaSorin
- Fujirebio
- Grifols
- Hologic
- Merck KGaA
- Ortho Clinical Diagnostics
- QIAGEN
- QuidelOrtho
- Randox Laboratories
- Roche Diagnostics
- Sekisui Diagnostics
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific
- Others
GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Molecular Diagnostic Reagents
- Immunoassay Reagents
- Clinical Chemistry Reagents
- Hematology Reagents
GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- PCR & RT-PCR
- ELISA
- Immunofluorescence
- Next-Generation Sequencing
GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032
- Viral Infections
- Bacterial Infections
- Fungal Infections
- Parasitic Infections
GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Disease Diagnosis
- Blood Screening
- Epidemiological Surveillance
GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic Laboratories
- Blood Banks
- Research Institutes
GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Diagnostic Reagents for Infectious Diseases Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Diagnostic Reagents for Infectious Diseases Market Snippet by Product Type
2.1.2. Diagnostic Reagents for Infectious Diseases Market Snippet by Technology
2.1.3. Diagnostic Reagents for Infectious Diseases Market Snippet by Disease Type
2.1.4. Diagnostic Reagents for Infectious Diseases Market Snippet by Application
2.1.5. Diagnostic Reagents for Infectious Diseases Market Snippet by End-User
2.1.6. Diagnostic Reagents for Infectious Diseases Market Snippet by Country
2.1.7. Diagnostic Reagents for Infectious Diseases Market Snippet by Region
2.2. Competitive Insights
3. Diagnostic Reagents for Infectious Diseases Key Market Trends
3.1. Diagnostic Reagents for Infectious Diseases Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Diagnostic Reagents for Infectious Diseases Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Diagnostic Reagents for Infectious Diseases Market Opportunities
3.4. Diagnostic Reagents for Infectious Diseases Market Future Trends
4. Diagnostic Reagents for Infectious Diseases Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Diagnostic Reagents for Infectious Diseases Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Diagnostic Reagents for Infectious Diseases Market Landscape
6.1. Diagnostic Reagents for Infectious Diseases Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Diagnostic Reagents for Infectious Diseases Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. Molecular Diagnostic Reagents
7.1.3. Immunoassay Reagents
7.1.4. Clinical Chemistry Reagents
7.1.5. Hematology Reagents
8. Diagnostic Reagents for Infectious Diseases Market – By Technology
8.1. Overview
8.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
8.1.2. PCR & RT-PCR
8.1.3. ELISA
8.1.4. Immunofluorescence
8.1.5. Next-Generation Sequencing
9. Diagnostic Reagents for Infectious Diseases Market – By Disease Type
9.1. Overview
9.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
9.1.2. Viral Infections
9.1.3. Bacterial Infections
9.1.4. Fungal Infections
9.1.5. Parasitic Infections
10. Diagnostic Reagents for Infectious Diseases Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
10.1.2. Disease Diagnosis
10.1.3. Blood Screening
10.1.4. Epidemiological Surveillance
11. Diagnostic Reagents for Infectious Diseases Market – By End-User
11.1. Overview
11.1.1. Segment Share Analysis, By End-User, 2024 & 2032 (%)
11.1.2. Hospitals
11.1.3. Diagnostic Laboratories
11.1.4. Blood Banks
11.1.5. Research Institutes
12. Diagnostic Reagents for Infectious Diseases Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. Diagnostic Reagents for Infectious Diseases Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Diagnostic Reagents for Infectious Diseases Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Abbott Laboratories
13.2.2. Agilent Technologies
13.2.3. Beckman Coulter
13.2.4. Becton, Dickinson and Company
13.2.5. Bio-Rad Laboratories
13.2.6. Danaher Corporation
13.2.7. DiaSorin
13.2.8. Fujirebio
13.2.9. Grifols
13.2.10. Hologic
13.2.11. Merck KGaA
13.2.12. Ortho Clinical Diagnostics
13.2.13. QIAGEN
13.2.14. QuidelOrtho
13.2.15. Randox Laboratories
13.2.16. Roche Diagnostics
13.2.17. Sekisui Diagnostics
13.2.18. Siemens Healthineers
13.2.19. Sysmex Corporation
13.2.20. Thermo Fisher Scientific
13.2.21. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Agilent Technologies
- Beckman Coulter
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Danaher Corporation
- DiaSorin
- Fujirebio
- Grifols
- Hologic
- Merck KGaA
- Ortho Clinical Diagnostics
- QIAGEN
- QuidelOrtho
- Randox Laboratories
- Roche Diagnostics
- Sekisui Diagnostics
- Siemens Healthineers
- Sysmex Corporation
- Thermo Fisher Scientific
- Others
GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- Molecular Diagnostic Reagents
- Immunoassay Reagents
- Clinical Chemistry Reagents
- Hematology Reagents
GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- PCR & RT-PCR
- ELISA
- Immunofluorescence
- Next-Generation Sequencing
GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019 - 2032
- Viral Infections
- Bacterial Infections
- Fungal Infections
- Parasitic Infections
GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032
- Disease Diagnosis
- Blood Screening
- Epidemiological Surveillance
GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic Laboratories
- Blood Banks
- Research Institutes
GLOBAL DIAGNOSTIC REAGENTS FOR INFECTIOUS DISEASES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
